NEW YORK (GenomeWeb News) — GE Healthcare may soon acquire Abbott Diagnostics in an attempt to fatten its molecular diagnostics play, according to news reports this morning.

GE has been eyeing the in vitro diagnostic space since it acquired Amersham in 2004, and the Abbott business could offer it a substantial position in that market.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

An analysis of UK Biobank data finds hemochromatosis to be more prevalent than thought, according to the BBC.

An analysis finds that female biomedical researchers receive fewer prizes than male ones, and when they do win prizes, they are less prestigious.

Federal researchers tell the Los Angeles Times that the shutdown is causing missed research opportunities as they try to keep their experiments going.

In Nature this week: improved genomic analysis using a graph genome reference, tumor mutational burden could predict clinical response to immune checkpoint inhibitors, and more.